"10.1371_journal.pone.0040962","none","2012-07-30T00:00:00Z","Anna L Gloyn; Johan H Faber; Daniel Malmodin; Gaya Thanabalasingham; Francis Lam; Per Magne Ueland; Mark I McCarthy; Katharine R Owen; Dorrit Baunsgaard","Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, United Kingdom; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom; Novo Nordisk A/S, Novo Nordisk, Måløv, Denmark; Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, United Kingdom; Section for Pharmacology, University of Bergen, Bergen, Norway; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom","Conceived and designed the experiments: LG MIM KRO DB. Performed the experiments: JHF DM FL PMU. Analyzed the data: ALG JHF DM GT KRO DB. Contributed reagents/materials/analysis tools: FL PMU DB. Wrote the paper: ALG JHF KRO DB.","The authors have read the journal's policy and have the following conflicts: the authors Dorrit Baunsgaard and Johan Faber are currently employed by the company Novo Nordisk A/S, Copenhagen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Johan Faber and Daniel Malmodin received their salary from the European Union project MolPAGE whilst carrying out the work described in this manuscript.","2012","07","Anna L Gloyn","ALG",9,TRUE,4,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
